Global Antibody Discovery Market

Global Antibody Discovery Market was valued USD 6.9 Billion in 2023 and projected to reach USD 13.7 Billion by 2030, growing at a CAGR of 9.0% during the forecast period of 2023-2030.

In recent years, the antibody discovery market has witnessed significant expansion, propelled by a growing need for precision therapeutics and the escalating incidence of chronic and infectious diseases. The process of antibody discovery entails the recognition and creation of antibodies designed to selectively bind to disease targets, presenting promising uses in diagnostics, therapeutics, and research. This market incorporates diverse technologies and platforms, including hybridoma technology, phage display, and transgenic animal models, facilitating the creation and enhancement of antibodies tailored for particular disease indications.

Increasing Demand for Targeted Therapeutics

The antibody discovery market is witnessing a surge in demand for targeted therapeutics, marking a notable trend in recent times. This heightened demand is driven by the recognition of the unique advantages offered by targeted therapeutic approaches. As precision medicine gains prominence, there is an increasing emphasis on developing antibodies that can specifically bind to disease targets. This targeted therapeutic strategy not only enhances treatment efficacy but also minimizes adverse effects on healthy tissues, showcasing a promising paradigm shift in the field of antibody discovery. The market is dynamically responding to this shift, with researchers and pharmaceutical entities actively pursuing innovative solutions to cater to the rising need for precision in therapeutic interventions.

Market Dynamics

Drivers:

• Rising Prevalence of Chronic and Infectious Diseases
• Increasing Research and Development Investment
• Advancements in antibody engineering

Opportunities:

• Development of new antibody-based therapies
• Development of novel antibody discovery platforms
• Expansion into new therapeutic areas

Increased adoption of personalized medicine

The Antibody Discovery Market is witnessing an increased adoption of personalized medicine, reflecting a paradigm shift in healthcare strategies. The recognition of individual variations in genetic makeup, responses to treatments, and disease manifestations has fueled the integration of personalized medicine into antibody discovery. This approach tailors medical interventions to the unique characteristics of each patient, maximizing treatment efficacy and minimizing adverse effects. The Antibody Discovery Market’s alignment with personalized medicine signifies a progressive move towards more precise and patient-centric therapeutic solutions, harnessing the potential of antibodies to cater to the specific needs and genetic profiles of individuals.

The market for Antibody Discovery is dominated by North America.

In 2022, the North American antibody discovery market is anticipated to dominate in the forecast period, propelled by an increase in cancer prevalence, a robust presence of the antibody discovery industry, and technological advancements in the R&D sector. For instance, in 2020, the American Cancer Society reported approximately 1.8 million new cancer cases and 606,520 cancer-related deaths in the U.S., underscoring the demand for therapeutic antibodies and stimulating market growth. The upsurge in funding facilitates the development of novel technologies, collaborative efforts spanning countries and organizations, and the exploration of existing antibody treatments, contributing to a deeper understanding of the immune system and the effective development of targeted antibodies. Moreover, augmented funding enables large-scale clinical trials essential for evaluating antibody efficacy, thereby enhancing the overall growth trajectory of the market.

On the other hand, the Asia-Pacific antibody discovery market is poised for expansion in the forecast period due to an increase in the incidence of cardiovascular diseases and other chronic health conditions. As reported by the Journal of Biomedical and Environmental Science in 2021, approximately 330 million individuals in China experienced cardiovascular diseases. The significance of antibody discovery becomes evident in the creation of innovative therapeutics for addressing cardiovascular ailments. Consequently, the rising prevalence of heart diseases amplifies the demand for antibody discovery, playing a pivotal role in propelling market growth.

The Phage Display Antibody Discovery Segment is Anticipated to Hold the Largest Market Share During the Forecast Period

Based on technology the antibody discovery market is segmented into Phage Display, Hybridoma, Transgenic Antibody Technology, Single B Cell Technology and Others. The dominance of the phage display segment in the antibody discovery market is anticipated to persist. Phage display facilitates the generation of diverse antibody libraries, encompassing fully human, humanized, or synthetic libraries, thereby increasing the likelihood of identifying antibodies with optimal therapeutic characteristics. This method finds widespread application in target discovery, enabling researchers to pinpoint antibodies effective against a broad spectrum of targets, including proteins, peptides, and small molecules. Its versatility renders it a favored option in drug discovery. Through phage display, researchers can screen for functional antibodies that not only bind to the target but also demonstrate specific biological activities, such as receptor blocking or pathogen neutralization. The technique allows the selection of high-affinity antibodies through successive rounds of panning and amplification, ensuring the isolation of antibodies with robust and specific binding to the target.

Major vendors in the global Antibody Discovery market are Biocytogen, Charles River Laboratories, Creative Biolabs, Danaher Corporation, Eurofins Scientific, Evotec, Fairjourney Biologics S.A, Genscript Technology Corporation, Sartorius AG, Twist Bioscience and Others.

Segmentations Analysis of Antibody Discovery Market: –

Major Segmentations Are Distributed as follows:

• By Source
  • Humanized Antibody
  • Human Antibody
  • Chimeric Antibody
  • Murine Antibody
• By Type
  • Monoclonal Antibodies (mAbs)
  • Polyclonal Antibodies
  • Recombinant Antibodies
• By Technology
  • Phage Display
  • Hybridoma
  • Transgenic Antibody Technology
  • Single B Cell Technology
  • Others
• End-user
  • Pharmaceutical & Biotechnology industry
  • Research laboratory
  • Academic laboratory
• By Region
  • North America
    • US
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of Latin America
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • U.K.
    • BENELUX
    • CIS & Russia
    • Nordics
    • Austria
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Thailand
    • Indonesia
    • Malaysia
    • Vietnam
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Nigeria
    • Egypt
    • Israel
    • Turkey
    • Rest of MEA

Recent Developments

• In November 2022, Beigene announced FDA approval of Opzelura (brexafolumab) for the treatment of adults with mantle cell lymphoma (MCL) who have relapsed after one or more lines of therapy
• In October 2023, AbbVie initiated Phase 1 clinical trial of Rovalpituzumab tesirine (Rova-T), an antibody-drug conjugate (ADC) targeting Nectin-4 for the treatment of solid tumors

Answers to Following Key Questions:

• What will be the Antibody Discovery Market’s Trends & growth rate? What analysis has been done of the prices, sales, and volume of the top producers of Antibody Discovery Market?
• What are the main forces behind worldwide Antibody Discovery Market? Which companies dominate Antibody Discovery Market?
• Which companies dominate Antibody Discovery Market? Which business possibilities, dangers, and tactics did they embrace in the market?
• What are the global Insight Engines industry’s suppliers’ opportunities and dangers in Antibody Discovery Market?
• What is the Insight Engines industry’s regional sales, income, and pricing analysis? In the Antibody Discovery Market, who are the distributors, traders, and resellers?
• What are the main geographic areas for various trades that are anticipated to have astounding expansion over the Antibody Discovery Market?
• What are the main geographical areas for various industries that are anticipated to observe astounding expansion for Antibody Discovery Market?
• What are the dominant revenue-generating regions for Antibody Discovery Market, as well as regional growth trends?
• By the end of the forecast period, what will the market size and growth rate be?
• What are the main Antibody Discovery Market trends that are influencing the market’s expansion?
• Which key product categories dominate Antibody Discovery Market? What is Antibody Discovery Market’s main applications?

In the coming years, which Antibody Discovery Market technology will dominate the market?telligence market technology will dominate the market?